These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32573522)

  • 1. Recent news in the treatment of hepatitis B virus-related cryogobulinemic vasculitis.
    Mazzaro C; Dal Maso L; Visentini M; Ermacora A; Tonizzo M; Gattei V; Andreone P
    Minerva Med; 2020 Dec; 111(6):566-572. PubMed ID: 32573522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review.
    Mazzaro C; Dal Maso L; Visentini M; Gitto S; Andreone P; Toffolutti F; Gattei V
    J Intern Med; 2019 Sep; 286(3):290-298. PubMed ID: 31124596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-related cryoglobulinemic vasculitis.
    Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
    Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC).
    Mazzaro C; Dal Maso L; Gragnani L; Visentini M; Saccardo F; Filippini D; Andreone P; Zignego AL; Gattei V; Monti G; Galli M; Quartuccio L
    Viruses; 2021 May; 13(6):. PubMed ID: 34070832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature.
    Mazzaro C; Bomben R; Visentini M; Gragnani L; Quartuccio L; Saccardo F; Sebastiani M; Filippini D; Lauletta G; Monti G; Gattei V
    Front Oncol; 2023; 13():1095780. PubMed ID: 36824142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C virus-related cryoglobulinemic vasculitis with renal involvement: current possibilities of treatment].
    Gordovskaia NB; Kozlovskaia LV; Milovanova SIu; Ignatova TM; Korotchaeva IuV
    Ter Arkh; 2013; 85(6):78-84. PubMed ID: 23866603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Delluc A; Piette JC; Cacoub P
    Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy.
    Mazzaro C; Adinolfi LE; Pozzato G; Nevola R; Zanier A; Serraino D; Andreone P; Fenoglio R; Sciascia S; Gattei V; Roccatello D
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
    De Vita S; Quartuccio L; Isola M; Mazzaro C; Scaini P; Lenzi M; Campanini M; Naclerio C; Tavoni A; Pietrogrande M; Ferri C; Mascia MT; Masolini P; Zabotti A; Maset M; Roccatello D; Zignego AL; Pioltelli P; Gabrielli A; Filippini D; Perrella O; Migliaresi S; Galli M; Bombardieri S; Monti G
    Arthritis Rheum; 2012 Mar; 64(3):843-53. PubMed ID: 22147661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC.
    Mazzaro C; Dal Maso L; Urraro T; Mauro E; Castelnovo L; Casarin P; Monti G; Gattei V; Zignego AL; Pozzato G
    Dig Liver Dis; 2016 Jul; 48(7):780-4. PubMed ID: 27106525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.
    Pietrogrande M; De Vita S; Zignego AL; Pioltelli P; Sansonno D; Sollima S; Atzeni F; Saccardo F; Quartuccio L; Bruno S; Bruno R; Campanini M; Candela M; Castelnovo L; Gabrielli A; Gaeta GB; Marson P; Mascia MT; Mazzaro C; Mazzotta F; Meroni P; Montecucco C; Ossi E; Piccinino F; Prati D; Puoti M; Riboldi P; Riva A; Roccatello D; Sagnelli E; Scaini P; Scarpato S; Sinico R; Taliani G; Tavoni A; Bonacci E; Renoldi P; Filippini D; Sarzi-Puttini P; Ferri C; Monti G; Galli M
    Autoimmun Rev; 2011 Jun; 10(8):444-54. PubMed ID: 21303705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues.
    Jansen L; Kootstra NA; van Dort KA; Takkenberg RB; Reesink HW; Zaaijer HL
    J Infect Dis; 2016 Jan; 213(2):224-32. PubMed ID: 26216905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.
    Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F
    Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2014 Feb; 34 Suppl 1():127-32. PubMed ID: 24373089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV-associated cryoglobulinemic vasculitis: remission after antiviral therapy with entecavir.
    Viganò M; Martin P; Cappelletti M; Fabrizi F
    Kidney Blood Press Res; 2014; 39(1):65-73. PubMed ID: 25011658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?
    Kao JH
    Liver Int; 2014 Feb; 34 Suppl 1():112-9. PubMed ID: 24373087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?
    Viganò M; Invernizzi F; Lampertico P
    Liver Int; 2015 Jan; 35 Suppl 1():107-13. PubMed ID: 25529095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?
    Viganò M; Mangia G; Lampertico P
    Liver Int; 2014 Feb; 34 Suppl 1():120-6. PubMed ID: 24373088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
    Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.